Advertisement

Komplementärmedizinische Maßnahmen in der gynäkologischen Onkologie

  • Hartmut HenßEmail author
Chapter
  • 10 Downloads

Zusammenfassung

Verfahren, die zunächst nicht Bestandteil der wissenschaftlichen Medizin sind, wurden schon immer, insbesondere bei schweren Erkrankungen, von Betroffenen genutzt. Diese haben in den letzten 10–20 Jahren weiter an Bedeutung zugenommen. Dabei werden die Begriffe „alternative Medizin“, „komplementäre Therapien“, „Naturheilkunde“, „biologische Behandlung“ von Erkrankten bzw. deren Angehörigen oft synonym gebraucht, was natürlich zu Missverständnissen führen kann, v. a. dann, wenn besondere Therapieverfahren wie Anthroposophie oder Homöopathie und auch außereuropäische Verfahren ebenfalls damit gemeint werden.

Literatur

  1. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J (2008) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer – results of a large case-control study. Carcinogenesis 29:93–99CrossRefGoogle Scholar
  2. Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, Wilcox H, Soslow R, Zaiber AG, Olson SH (2009) Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Yersey. Cancer Causes Control 20:1117–1127CrossRefGoogle Scholar
  3. Bandera EV, King M, Chandran U, Paddock L, Rodriguez-Rodriguez L, Olson SH (2011) Phytoestrogens consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health 11:40CrossRefGoogle Scholar
  4. Banik U, Parasuraman S, Adhikary AK, Othman NH (2017) Curcumin: the spicy modulation of breast carcinogenesis. J Exp Clin Canc Res 36:98.  https://doi.org/10.1186/s13046-017-0566-5CrossRefGoogle Scholar
  5. Banerjee B, Vadiraj HS, Ram A et al (2007) Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiation. Integr Cancer Ther 6(3):242–251CrossRefGoogle Scholar
  6. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C (2007) Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treatm Rev 33:407–418CrossRefGoogle Scholar
  7. Buck K, Vrieling A, Zaneddin AK, Becker S, Hüsing A, Kaaks R, Linseisen J, Flesch-Janys D, Chang-Claude J (2011) Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol 29:3730–3738CrossRefGoogle Scholar
  8. Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, Ciccone G, Berruti A (2011) Prognostic role of vitamin D status and efficacy of vitamin d supplementation in cancer patients. Oncologist 16:1215–1227CrossRefGoogle Scholar
  9. Cassileth BR, Lucarelli CD (2003) Herb-drug interactions in oncology. BC Becker Inc, HamiltonGoogle Scholar
  10. Chimentoi A, Sirianni R, Saturnino C et al (2016) Resveratrol and its analogs as antitumoral agents for breast cancer. Mini-Rev Med Chem 16:699–709CrossRefGoogle Scholar
  11. Chlebowski RT (2011) Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res 13:217–225CrossRefGoogle Scholar
  12. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW et al (2006) Dietary fat reductions and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98:1767–1776CrossRefGoogle Scholar
  13. Danhauer SC, Mihalko SL, Russell GB, Campbell CR, Lynn F, Daley K, Levine EA (2009) Restorative yoga for women with breast cancer: findings from a randomized pilot study. Psychooncology 18(4):360–368CrossRefGoogle Scholar
  14. Dimeo FC (2011) Bedeutung von Sport in der onkologischen Akutbehandlung. Forum 26:31–33CrossRefGoogle Scholar
  15. Fasching PA, HübnerJ, Kleeberg UR (2009) Körperliche Bewegung und Sport zur Prävention und Behandlung von Krebskrankheiten. Onkologe 15:696–701Google Scholar
  16. Galliford M, Robinson S, Bridge P, Carmichael MA (2017) Salute tot he sun: a new dawn in yoga therapy for breast cancer. J Med Radiat Sci 64:232–238CrossRefGoogle Scholar
  17. Greenlee H, Hershman DL, Jacobson J (2009) Use of antioxydant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 115:437–452CrossRefGoogle Scholar
  18. Guha N, Kwan ML, Quesenberrry CP, Weltzien EK, Castillo AL, Caan BJ (2009) Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors. Breast Cancer Res Treat 118:395–405CrossRefGoogle Scholar
  19. Gupta D, Lis CG (2010) vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in ovarian cancer support care cancer 18:373–381PubMedGoogle Scholar
  20. Helzlsouer KJ (2010) Overview of the cohort consortium vitamin d pooling project of rarer cancers. Am J Epidemiol 172:4–9CrossRefGoogle Scholar
  21. Horneber M, Bueschel G, Huber R, Linde K, Rostock M (2010) Mistletoe therapy in oncology. Cochrane Database Syst Rev Issue 2: CD003297Google Scholar
  22. Horn-Ross PL, John EM, Canchola AJ, Stewart L, Lee MM (2003) Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95:1158–1164CrossRefGoogle Scholar
  23. Irwin ML, smith AW, Mc Tiernan A, Ballard-Barbash, Cronin K, Gilliland F, Baumgartner RN, Baumgartner KB, Bernstein L (2008) Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the Health, Eating, Activity, and Lifestyle Study. J Clin Oncol 26:3958–3964Google Scholar
  24. Jablonska E, Socha K, Reska E et al (2017) Cadmium, arsenic, selenium and iron -Implications for tumorprogression in breast cancer. Envirom Toxicol Pharmacol 53:151–157Google Scholar
  25. Kim Y, Je Y (2014) Vitamin D intake, blood 25 (OH)D levels, and breast cancer risk or mortality: a meta-analysis. Brit J Cancer 110:232–238Google Scholar
  26. LecomteS, Demay F, Ferrière F, Pakdel F (2017) Phytochemicals Targeting Estrogen Receptors: Beneficial Rather than Adverse Effects? Int J Mol Sci 18:1381.  https://doi.org/10.3390/ijms18071381
  27. Liu B, Edgerton S, Yang X, Kim A, Ordonez-Ercan D, Mason T, Alvarez K, Mc Kimmey C, Lu N, Thor A (2005) Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res 65:879–886PubMedGoogle Scholar
  28. Mohr SB, Gorham ED, Kim J, Hofflich H, Garland CF (2014) Meta-analysis of Vitamin D Sufficiency for Improving Survival of Patients with Breast Cancer. Anticancer Res 34:1163–1166PubMedGoogle Scholar
  29. Molassiotis A, Helin AM, Dabbour R, Hummerston S (2007) The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients. Complement Ther Med 15:3–12CrossRefGoogle Scholar
  30. Moore SC, Gierach GL, Schatzkin A, Matthews CE (2010) Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 103:933–938CrossRefGoogle Scholar
  31. Moore SC, Lee I-M, Weiderpass E, Campbell PT, Sampson JN (2016) Association of leisure – time physical activity with risks of 26 types of cancer in 1.44 million adults. JAMA Intern med.  https://doi.org/10.1001/jamainternmed.2016.1548CrossRefPubMedPubMedCentralGoogle Scholar
  32. Moorman PG, Jones LW, Akushevich L, Schildkraut JM (2011) Recreational physical activity and ovarian cancer risk and survival. Ann Epidemiol 21:178–187CrossRefGoogle Scholar
  33. Mücke R, Schomburg L, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, Buentzel J, Kundt G, Prott FJ, De Vries A, Stoll G, Kisters K, Bruns F, Schaefer U, Willich N, Micke O (2010) Multicenter, phase 3 trial comparing selenium supplemantation with obsevation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 78:828–835CrossRefGoogle Scholar
  34. Münstedt K (Hrsg) (2008) Alternative und komplementäre Therapieverfahren in der Gynäkologie aus evidenzbasierter Sicht. Ecomed, LandsbergGoogle Scholar
  35. Neill AS, Ibiebele TI, Lahmann PH et al (2014) Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers. Brit J Nutrition 111:1430–1440CrossRefGoogle Scholar
  36. Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D (2009) Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 21:608–614CrossRefGoogle Scholar
  37. Park J, Linde K, Manheimer E, Molsberger A, Sherman K, Smith C, Sung J, Vickers A, Schnyer R (2008) The status and future of acupuncture clincal research. J Altern Complement Med 14:871–881CrossRefGoogle Scholar
  38. Patisaul HB, Jefferson W (2010) The pros and cons of phytoestrogens. Front Neuroendocrinol 31:400–419CrossRefGoogle Scholar
  39. Rostock M, Saller R (2011) Komplementärmedizin in der Behandlung klimakterischer Beschwerden bei Patientinnen mit Brustkrebs. Forum 26:30–34CrossRefGoogle Scholar
  40. Sandsveden M, Manjer J (2017) Selenium and breast cancer risk: a prospective nested case-control study on serum selenium levels, smoking habits and overweight. Int J Cancer 141:1741–1750CrossRefGoogle Scholar
  41. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443CrossRefGoogle Scholar
  42. This P, de Cremoux P, Leclercq G, Jacquot Y (2011) A critical view of the effects of phytoestrogens on hot flashes and breast cancer risk. Maturitas 70:222–226CrossRefGoogle Scholar
  43. Velentzis S, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR (2008) Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer 44:1799–1806CrossRefGoogle Scholar
  44. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2011) Meta-analysis: circulating vitamin D and ovarian cancer risk. Gynecol Oncol 121:369–375CrossRefGoogle Scholar
  45. Zhou Y, Chlebowski R, LaMonte MJ et al (2014) Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer. Gynecol Oncol 133:4–10CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.FreiburgDeutschland

Personalised recommendations